Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Clara M. Rivera-Pazos"'
Autor:
Héctor I. Saldivar-Cerón, Olga Villamar-Cruz, Claire M. Wells, Ibrahim Oguz, Federica Spaggiari, Jonathan Chernoff, Genaro Patiño-López, Sara Huerta-Yepez, Mayra Montecillo-Aguado, Clara M. Rivera-Pazos, Marco A. Loza-Mejía, Alonso Vivar-Sierra, Paola Briseño-Díaz, Alejandro Zentella-Dehesa, Alfonso Leon-Del-Rio, Alejandro López-Saavedra, Laura Padierna-Mota, María de Jesús Ibarra-Sánchez, José Esparza-López, Rosaura Hernández-Rivas, Luis E. Arias-Romero
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
p21-Activated kinase-1 (Pak1) is frequently overexpressed and/or amplified in human breast cancer and is necessary for transformation of mammary epithelial cells. Here, we show that Pak1 interacts with and phosphorylates the Calcium/Calmodulin-depend
Externí odkaz:
https://doaj.org/article/ec87f1dbc3d246fe88a90ccb748ac16d
Autor:
Guillermina J. Baay-Guzman, Clara M. Rivera-Pazos, Elizabeth A. Grimm, Gabriela Antonio-Andres, Suhendan Ekmekcioglu, Mario I. Vega, Sara Huerta-Yepez
Publikováno v:
Forum on Immunopathological Diseases and Therapeutics. 2:189-194
Autor:
Lee Goodglick, Steve Horvath, Erin L. Maresh, Clara M. Rivera-Pazos, Devasis Chatterjee, Nam K. Yoon, Vei Mah, David Chia, Benjamin Bonavida, Angeles Hernandez-Cueto, Mario I. Vega, Sara Huerta-Yepez
Publikováno v:
Huerta-Yepez, Sara; Yoon, Nam K; Hernandez-Cueto, Angeles; Mah, Vei; Rivera-Pazos, Clara M; Chatterjee, Devasis; et al.(2011). Expression of Phosphorylated Raf Kinase Inhibitor Protein (pRKIP) is a Predictor of Lung Cancer Survival. BMC Cancer, 11(1), 259. doi: http://dx.doi.org/10.1186/1471-2407-11-259. Retrieved from: http://www.escholarship.org/uc/item/45n0h8j2
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 259 (2011)
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 259 (2011)
Background Raf-1 kinase inhibitor protein (RKIP) has been reported to negatively regulate signal kinases of major survival pathways. RKIP activity is modulated in part by phosphorylation on Serine 153 by protein kinase C, which leads to dissociation
Autor:
Haiming Chen, Mario I. Vega, Clara M Rivera Pazos, Giancarlo Castellano, Stavroula Baritaki, Graziella Malaponte, Massimo Libra, Loredana Militello, James R. Berenson, Sara Huerta-Yepez, Silvana Canevari, Ma Del Lourdes Cabrera-Munoz
Patients with multiple myeloma (MM) develop resistance to conven- tional therapies. The underlying molecular mechanism responsible for resistance is not clear. We have reported in solid tumors that transcription factor Yin Yang 1 (YY1) is overexpress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f7e8ed28b00609fa4cf38ca2939ac9
http://hdl.handle.net/20.500.11769/37646
http://hdl.handle.net/20.500.11769/37646
Autor:
Ma de Lourdes Cabera-Muñoz, Clara M. Rivera-Pazos, Haiming Chen, Benjamin Bonavida, Sara Huerta-Yepez, Hong Liu, Suzie Vardanyan, Manuel L. Penichet, James R. Berenson, Stavroula Baritaki
Publikováno v:
Blood. 118:3991-3991
Abstract 3991 The transcription factor Yin-Yang 1 (YY1) is a multi-functional DNA-binding protein which can activate, repress, or initiate transcription depending on the context in which it binds. We have previously reported that YY1 is a repressor f
Autor:
Elizabeth A Grimm, Stavroula Baritaki, Ekmekcioglu Suhendan, Mario I. Vega, Gabriela Antonio-Andres, Graziella Malaponte, Benjamin Bonavida, Kam C. Yeung, Sara Huerta-Yepez, Guillermina J. Baay-Guzman, Clara M. Rivera-Pazos
Publikováno v:
Cancer Research. 70:3374-3374
The Raf Kinase Inhibitor Protein (RKIP) is a member of the phosphatidylethanolamine binding protein family (PEBP). RKIP binds to Raf-1 and prevents the activation of the ERK 1/2 cascade. RKIP expression is diminished in many primary cancers and is ab
Autor:
Otoniel Martinez-Maza, Gabriela Antonio-Andres, Miriam Hernandez-Atenogenes, Clara M. Rivera-Pazos, Benjamin Bonavida, Altagracia Maldonado-Valenzuela, Juan C. Vazquez-Islas, Melisa Martinez-Paniagua, Sara Huerta-Yepez, Mario I. Vega, Bernardo Martinez-Miguel
Publikováno v:
Cancer Research. 70:806-806
Krüppel-like factor 4 (KLF-4) is highly expressed in epithelial tissues such as gut and skin. Several studies based on clinical evidence suggest that KLF-4 functions as a tumor suppressor in cancer of colon, bladder, stomach and in leukemia. In con
Autor:
Ali R. Jazirehi, Stavroula Baritaki, Guillermina J. Baay-Guzman, Ekmekcioglu Suhendan, Clara M. Rivera-Pazos, Marioi I. Vega, Gabriela Antonio-Andres, Sara Huerta-Yepez, Graziella Malaponte, Elizabeth A. Grimm, Benjamin Bonavida
Publikováno v:
Cancer Research. 70:2242-2242
Over 90% of melanoma express oncogenic mutations in BRAF at the V600E position. Most of the transforming activity of the BRAF V600E is thought to result through the activation of the mitogen-activated protein kinase (MAPK) pathway. The discovery of B
Autor:
Otoniel Martinez-Maza, Mario I. Vega, Clara M. Rivera-Pazos, Benjamin Bonavida, Sara Huerta-Yepez, James R. Berenson
Publikováno v:
Blood. 114:1932-1932
Abstract 1932 Poster Board I-955 Patients infected with HIV develop AIDS-related Non-Hodgkin's lymphoma (ARL). The onset and pathogenesis of ARL has been the subject of many studies and several mechanisms have been proposed including immunosuppressio
Autor:
Stavroula Baritaki, Ma de Lourdes Cabera-Muñoz, Kam C. Yeung, Clara M. Rivera-Pazos, Sara Huerta-Yepez, James R. Berenson, Benjamin Bonavida, Haiming Chen, Manuel L. Penichet
Publikováno v:
Blood. 112:2729-2729
Objective and Rationale Raf-1 kinase inhibitor protein (RKIP) is a modulator of cell signaling and survival that functions as an endogenous inhibitor of multiple kinases, including kinases involved in the Raf-1/MEK/ERK and NF-kB pathways. RKIP has be